Events

Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial

More Information

2021-11-29T06:32:41+00:00November 29th, 2021|Events|
Go to Top